The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.

A new AAN position statement outlines guidelines for switching from branded biologics to biosimilars, while preserving clinical autonomy for physicians.

The AAP released its 2026 childhood immunization schedule, maintaining routine vaccine recommendations for several diseases despite revised CDC guidelines.

The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.

Common blood biomarkers, like those reflecting inflammatory, vascular, metabolic, and neurodegenerative processes, can predict multimorbidity.

Midlife influenza immunization is not associated with an altered risk for Parkinson disease later in life, according to a ...

Low-sodium oxybate reduces 24-hour sleep duration and daytime napping in adults with idiopathic hypersomnia, according to a phase 3 trial analysis.

Higher 2-hour, postload glucose was associated with a 69% increased Alzheimer dementia risk (odds ratio 1.69). HealthDay News — Spikes in blood sugar after meals may increase the risk for Alzheimer ...

Jeffrey L. Jackson, M.D., M.P.H., from the Medical College of Wisconsin in Milwaukee, and colleagues estimated the prevalence of difficult patient encounters among adults seen in nonpsychiatric ...

Valneva has made the decision to withdraw the Biologics License Application for its chikungunya vaccine Ixchiq®.

Mediterranean, plant-based, and anti-inflammatory diets are associated with reduced C-reactive protein levels in people with multiple sclerosis.

Increased p-Tau181 levels may be associated with neurological manifestations of N-PASC consistent with central damage.